Objectives: To describe the clinical and laboratory characteristics of patients on long-term home oxygen therapy followed up by the home care program of Hospital das Clínicas, School of Medicine, Universidade de São Paulo, during a period of 8 years; to compare groups with and without secondary pulmonary hypertension; and to estimate the cost of the program using oxygen concentrators vs. oxygen cylinders provided by the hospital.
Introduction
The number of patients requiring long-term home oxygen therapy (LTOT) has been increasing every year. 1 This therapeutic method has been used more often to treat several chronic lung diseases in pediatric patients with the purpose of reducing morbidity and improving the patients' quality of life. [2] [3] [4] [5] This practice makes it possible to optimize bed occupancy rates, reduce the duration and number of hospitalizations and thus decrease hospital costs. [4] [5] [6] [7] [8] LTOT is recommended for children and adolescents mainly because of its importance in providing and maintaining Long-term home oxygen therapy in children and adolescents: analysis of clinical use and costs of a home care program patients' appropriate cognitive development and height and weight growth, preventing sudden death in infants and minimizing the effects of pulmonary hypertension (PH). 9, 10 There are few studies in Brazil analyzing the characteristics of the pediatric population using LTOT as a therapeutic resource and describing the major diseases and specific conditions that require this intervention. On the other hand, updated national pediatric guidelines have not been established regarding the clinical and laboratory parameters that guide its main recommendations and provide guidance regarding the advantages and disadvantages of the main methods of administration, estimates of duration, and quantification of costs.
Based on this context, we conducted a study whose objectives were: to describe and characterize the population of children and adolescents followed up at the Unit of were compared using the chi-square test; and Kaplan-Meier curves were compared using the Logrank test. We used the statistical software SPSS 13.0 for the analyses and the significance level was set at 5%.
Cost analysis
We decided to calculate the average monthly cost of the 
Results
Most patients (68%) lived in São Paulo; 53% were male; the age at the beginning of LTOT ranged from 0.1 to 21.5 Table 1 Distribution of 165 patients on LTOT according to the underlying diseases LTOT = long-term home oxygen therapy. *Ciliary dyskinesia (n = 2), deposit disease (n = 2), hepatopulmonary syndrome (n = 2), pulmonary veno-occlusive disease (n = 1), alpha-1 antitrypsin deficiency (n = 1), chronic lung disease related to long-term mechanical ventilation (n = 1), lymphocytic interstitial pneumonitis associated with the human immunodeficiency virus (n = 1), Prader-Willi syndrome (n = 1), lung entrapment (n = 1), and sickle cell anemia (n = 1).
Diagnosis n (%)
Cystic fibrosis 36 (22) Bronchopulmonary dysplasia 31 (19) Bronchiolitis obliterans 25 ( years (median: 3.6 years); and about 1/3 of the sample initiated the use of O 2 in the first year of life.
The main diagnoses of chronic underlying disease were: cystic fibrosis, bronchopulmonary dysplasia, and bronchiolitis obliterans (Table 1) .
LTOT was continuous in 65% of patients, and 87% used flows lower than 2 L/min. The most often used device for O 2 administration was nasal cannula (87%), and the providing system was an oxygen concentrator (58%). The median duration of O 2 use was 7 years and the median of survival time was 13.4 years.
Regarding the main underlying diseases, the median duration of O 2 use was 1.6 years for patients with cystic fibrosis, 0.9 years for those with bronchopulmonary dysplasia, and 2.3 years for patients with bronchiolitis obliterans. At the end of the study, there was a rate of 22%
of deaths among patients with cystic fibrosis, 3% among bronchopulmonary dysplasia patients, and 4% among patients with bronchiolitis obliterans (Figure 1 ).
Of the 33 patients who could undergo spirometry, 70%
had severe obstructive lung disease. Doppler echocardiogram was performed in 134 patients; 51% of them had SPH.
Thirteen (18.8%) patients with SPH compared to three 
Discussion
In the present study, there was a slight male prevalence for LTOT recommendation in children, in our study, this was the second most frequent underlying disease (19%), being preceded only by cystic fibrosis (22%), which can be explained by the fact that the Children's Institute of HC-FMUSP is an excellence center for this disease. 9, 16 Similarly to other studies, in the present study, most patients with bronchopulmonary dysplasia received O 2 for a period shorter than 1 year (median 11 months), but slightly longer than the period found by other authors (median 3-8 months). 10, [15] [16] [17] In our study, bronchiolitis obliterans was the third most frequent underlying disease (15%) with a median duration of O 2 use of 2.3 years. Similarly, Norzila et al. 16 found a frequency of 17% and the median duration of O 2 use was also 2.3 years in their study (n = 12). Another prospective
Chilean study followed up 18 children diagnosed with bronchiolitis obliterans during 5 years; of these, 27.8%
needed LTOT, and after 1 year LTOT was discontinued in 100% of the cases. 18 Patients with cystic fibrosis showed a much higher percentage of deaths (22%) than patients with bronchopulmonary dysplasia (3%) and those with bronchiolitis obliterans (4%). Such findings were expected because, for cases of cystic fibrosis and neuromuscular disease, LTOT is usually recommended in more advanced stages with poor prognosis, unlike other child and infant diseases, for which, in most cases, LTOT is recommended with the prospect of discontinuation after a certain period of time. 10 In December 2008, the database of the British Thoracic Society, which includes records of England and Wales, presented a sample of 828 children on LTOT. 10 The main diagnoses of this sample were: bronchopulmonary dysplasia (60%), neuropathy (7%), neuromuscular disease (7%), heart disease (5%), and interstitial lung disease (2%). 10 Considering this database, only the diagnosis of heart disease showed the same frequency as that found in our study (5%).
According to these findings, each study had different frequencies for the diagnoses related to the underlying diseases. This may be related to the particular characteristics of each center, such as, for example, to be an excellence center for a specific type of disease and/or to use different criteria to recommend LTOT use and its discontinuation.
Among all patients who were on night LTOT (35%), a large percentage of them (56%) had started the process of discontinuation. However, there was continuous daily O 2 use in most cases (65%), with prevalence of flows lower than 2 L/min using nasal cannula (87%), which is equivalent to one inspired fraction of oxygen (FiO 2 ) of 28%. In a study involving children with post-infectious bronchiolitis on LTOT, the authors also demonstrated that low concentrations of O 2 (FiO 2 : 25 to 40%) were sufficient to achieve optimal levels of oxygen saturation in most patients. 19 As a result of the low flows used, the nasal cannula, similarly to what happens in most services, is the oxygen administration device most widely used in adults, children and adolescents because it is more comfortable than the mask and ensures constant oxygenation. 10, 20 Long-term home oxygen therapy in children -Munhoz AS et al.
Two studies have reported that most patients remained on LTOT for long periods; even so, these periods were shorter than the one found in our study (median = 7 years).
In one of these studies, the sample included only patients with bronchiolitis obliterans (median = 3.2 years); in the other study, (median = 1 year), 75% of patients had this diagnosis. In both studies, the authors have report that at the end of the study, most patients had good clinical outcome. 15, 19 One of the great differences between our study and the other studies published in Brazil and abroad is related to the approach of survival in children and adolescents on LTOT, since we could not find scientific publications on this topic.
In our study, we demonstrated that the median survival of 165 patients after they started using LTOT was 13.4 years, and 67% of patients survived until the end of the study.
With regard to pulmonary function tests, most of the 33 patients who underwent spirometry had severe obstructive lung disease (70%). This can only be explained by the fact that most patients had cystic fibrosis or bronchiolitis obliterans, and their median age was 16 years. In this context, the disease is in advanced stage, especially in patients with cystic fibrosis, which explains the result obtained on the spirometry.
The high percentage of patients diagnosed with SPH (51.49%) on the echocardiogram draws attention to the fact that there is high incidence of SPH in adolescents and children who need LTOT. Unfortunately, the diagnosis of SPH is usually delayed, and this disease is often underdiagnosed, which worsens the prognosis because of late treatment. 13 Most patients with and without SPH used O 2 continuously, and there was no statistically significant difference between the two groups regarding the time of daily O 2 use, but there was a higher percentage of patients with SPH who required oxygen flows higher than 2 L/min, and such difference was statistically significant. The group of patients with SPH also had longer time of O 2 use; a statistically significant difference when compared with those without SPH, which was expected because SPH is one of the aggravating factors of the underlying disease.
Based on these findings, we concluded that patients with SPH need higher O 2 flows for longer periods, which is probably related to the fact that they are more severe patients. The survival time was shorter in the group with SPH compared with the group without SPH, but this difference was not statistically significant.
Because this was a retrospective and long-term study, one of its limitations is related to data collection regarding the tests (echocardiogram and spirometry). First, not all patients underwent the tests, and when these were performed, they were conducted at different times, which prevents us from correlating such data with the patients'
clinical conditions and LTOT phase.
It is important to highlight that although LTOT is an expensive therapy, hospitalization has higher costs compared with other clinical and surgical treatments used to improve the quality of life and increase survival of adults with chronic obstructive pulmonary disease. 21, 22 In addition, studies in adults with chronic obstructive pulmonary disease have shown a decrease in the use of emergency services by these patients after they start using home oxygen therapy. 1, 23, 24 A study published in 2004, comparing two medical care services for a period of 2 years with regard to the frequency of LTOT recommendation for oxygen-dependent patients admitted to the neonatal unit, showed that the costs related to post-discharge care were similar for both services. However, the total cost was significantly higher in the service where LTOT recommendation was less frequent because of the costs with longer hospital stays. Similarly to what happens in our service, in other national excellence centers for pediatric respiratory care, the use of concentrators is more prevalent. 15 As there are few studies on LTOT in children and adolescents, there is also lack of consensus about several aspects of the therapeutic method used in this population. as multicenter trials, are needed in this age group. 9 It would be also interesting to conduct studies evaluating these patients' adherence to treatment, an issue that has been extensively focused on adults, because of its importance in terms of the clinical outcome of patients after LTOT initiation, as well as with respect to the burden it poses on the health system. There is a shortage of Brazilian studies describing the prevalence and cost of LTOT in several states and municipalities.
We conclude that in the present sample of the Children's
Institute of HC-FMUSP, which provides tertiary care for highly complex diseases, LTOT was used in different chronic diseases for correction of hypoxemia and SPH most often in infants and preschool-aged patients, and cystic fibrosis, bronchopulmonary dysplasia, and bronchiolitis obliterans were the most prevalent diseases. LTOT duration for patients with these pathologies was quite long. Based on our results, we reached the conclusion that SPH was also frequent in patients on LTOT and that its presence is associated with the need of longer treatment and increased oxygen flows with no association with survival time.
In terms of costs, it can be inferred by the estimates obtained in our study that the use of concentrators instead of oxygen cylinders in LTOT programs for children and adolescents may significantly reduce the economic burden of this therapeutic resource.
